CX3CL1 and pulmonary arterial hypertension: The inflammatory mechanism of chemokine, fractalkine, and its receptor, Cx3CR1, in the lungs of patients with pulmonary hypertension may play a role in the natural development of pulmonary hypertension, proving the possibility of an inflammatory component in pulmonary hypertension [23].